0

RADRES 2018 – Looking forward to meeting you!

Eat, Sleep, Radiate, Repeat. Xstrahl is delighted to invite you to attend its booth at the 64th Annual Meeting of the Radiation Research Society held at the Historic Hilton Chicago Hotel on [...]

0

Xstrahl In Action: Inhibition of ataxia telangiectasia related-3 improves therapeutic index

Cancer treatment has come a long way in a short time, however as new drugs and treatments are developed, the therapeutic index of treatments needs to be assessed. In their study “Inhibition of [...]

0

Xstrahl In Action: Stereotactic Radiotherapy Increases Functionally Suppressive Regulatory T Cells

Radiotherapy enhances innate and adaptive antitumor immunity; however, the effects of radiation on suppressive immune cells, such as regulatory T cells (Treg), in the tumor microenvironment (TME) [...]

0

Sydney Vital is the first research centre in Australia to acquire an Xstrahl SARRP

Sydney Vital, a translational cancer research centre funded by the Cancer Institute New South Wales (CINSW) and the University of Sydney, is the first centre in Australia to acquire an Xstrahl [...]

0

Xstrahl In Action: BioXmark for high-precision radiotherapy in an orthotopic pancreatic tumor mouse model

High-precision radiotherapy requires precise positioning, particularly with high single doses. Fiducial markers in combination with onboard imaging are excellent tools to support this. In the [...]